VisionPoint Advisory Group’s Boston Scientific BSX Stock Holding History

VisionPoint Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,179	Closed	-$208K	–	449
2025 Q4	$208K	Sell	2,179 -91	-4%	-$8.92K	0.04%	382
2025 Q3	$222K	Buy	+2,270	New	+$235K	0.04%	368
2024 Q3	–	Sell	-198	Closed	-$15.2K	–	313
2024 Q2	$15.2K	Buy	198 +187	+1,700%	+$13.7K	0.01%	435
2024 Q1	$753	Buy	+11	New	+$707	﹤0.01%	733

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VisionPoint Advisory Group's BSX Position: Q1 2026 in Review

VisionPoint Advisory Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,179 shares — an estimated $208K sold.

VisionPoint Advisory Group first reported a position in BSX in Q1 2024 and held it in 4 quarters. The position peaked at $222K in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

VisionPoint Advisory Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
VisionPoint Advisory Group sold 2,179 Boston Scientific shares in Q1 2026, an estimated $208K.
VisionPoint Advisory Group first reported a position in Boston Scientific in Q1 2024 and held it in 4 quarters.
VisionPoint Advisory Group's Boston Scientific position peaked at $222K in Q3 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on VisionPoint Advisory Group's 13F filing for Q1 2026, filed 7 May 2026.